![](/img/cover-not-exists.png)
A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial)
Stürner, Klarissa Hanja, Stellmann, Jan-Patrick, Dörr, Jan, Paul, Friedemann, Friede, Tim, Schammler, Sven, Reinhardt, Stefanie, Gellissen, Susanne, Weissflog, Gainet, Faizy, Tobias Djamsched, Werz, OLanguage:
english
Journal:
Journal of Neurology, Neurosurgery & Psychiatry
DOI:
10.1136/jnnp-2017-317101
Date:
December, 2017
File:
PDF, 1.25 MB
english, 2017